The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

Across all practice settings — including inpatient, ambulatory, and community care — nurses can assess, identify, and implement strategies to address patient-related barriers to clinical trial ...

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” ...

In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

Documentation is especially important for nurse practitioners in cancer research and can lead to improved patient recruitment ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Kansas City, Kan.-based University of Kansas Cancer Center has partnered with the Kansas City (Mo.) Veteran Medical Center to ...

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...

Florida Cancer Specialists & Research Institute, LLC (FCS) physicians are participating in the Florida Society of Clinical ...

Richardson, has published promising findings from the past seven years of research into a new approach for the treatment of ...

Yunu, creator of the industry’s first end-to-end clinical trial imaging workflow platform supporting sites, CROs and pharma, ...